| VYNE Therapeutics Inc. VYNE | $1.37M | 3.06 | 445,000 | -33.4% | -$685,073.57 | 0.87 | |
| Karyopharm Therapeutics Inc. KPTI | $1.7M | 0.96 | 1.13M | 0% | +$0 | 1.08 | |
| uniQure N.V. QURE | $2.39M | 0.95 | 460,000 | +9.26% | +$202,670.00 | 1.52 | |
| Coherus BioSciences, Inc. CHRS | $2.39M | 0.87 | 1M | 0% | +$0 | 1.52 | |
| Stereotaxis, Inc. STXS | $1.57M | 0.73 | 600,000 | 0% | +$0 | 0.99 | |
AG Mortgage Investment Trust, Inc. MITT | $1.28M | 0.71 | 208,879 | 0% | +$0 | 0.81 | |
DocGo Inc. DCGO | $2.63M | 0.64 | 650,000 | +109.68% | +$1.37M | 1.67 | |
| UroGen Pharma Ltd. URGN | $2.16M | 0.4 | 143,898 | -7.16% | -$166,530.00 | 1.37 | |
| BioCryst Pharmaceuticals, Inc. BCRX | $3.43M | 0.33 | 675,000 | 0% | +$0 | 2.17 | |
| KalVista Pharmaceuticals, Inc. KALV | $1.54M | 0.31 | 130,000 | -5.11% | -$83,020.00 | 0.98 | |
| Dynex Capital, Inc. DX | $2.26M | 0.28 | 181,492 | 0% | +$0 | 1.43 | |
Perspective Therapeutics, Inc. CATX | $2.09M | 0.28 | 1.76M | New | +$2.09M | 1.33 | |
| Ellington Financial Inc. EFC | $2.62M | 0.26 | 221,602 | 0% | +$0 | 1.66 | |
| Pacira BioSciences, Inc. PCRX | $3.43M | 0.25 | 117,500 | 0% | +$0 | 2.18 | |
ArriVent BioPharma, Inc. Common Stock AVBP | $1.48M | 0.25 | 83,000 | New | +$1.48M | 0.94 | |
Tourmaline Bio, Inc. TRML | $1.4M | 0.24 | 61,100 | New | +$1.4M | 0.89 | |
New York Mortgage Trust, Inc. NYMT | $1.45M | 0.22 | 200,963 | 0% | +$0 | 0.92 | |
Redwood Trust, Inc. RWT | $1.84M | 0.22 | 288,343 | +96.7% | +$902,947.54 | 1.17 | |
| Harmony Biosciences Holdings, Inc. HRMY | $4.1M | 0.22 | 122,000 | 0% | +$0 | 2.6 | |
| Mirum Pharmaceuticals, Inc. MIRM | $2.36M | 0.2 | 94,000 | +88% | +$1.11M | 1.5 | |
Embecta Corp. EMBC | $1.48M | 0.19 | 111,500 | -44.25% | -$1.17M | 0.94 | |
| MFA Financial, Inc. MFA | $1.91M | 0.16 | 167,725 | +17.52% | +$285,249.96 | 1.21 | |
Galapagos NV GLPG | $3.38M | 0.16 | 105,000 | 0% | +$0 | 2.15 | |
| Bicycle Therapeutics plc BCYC | $1.49M | 0.14 | 60,000 | New | +$1.49M | 0.95 | |
| Inari Medical, Inc. NARI | $3.02M | 0.11 | 63,000 | +1,160% | +$2.78M | 1.92 | |
| Dynavax Technologies Corporation DVAX | $1.52M | 0.09 | 122,500 | +22.5% | +$279,225.00 | 0.96 | |
Rithm Capital Corp. RITM | $4.7M | 0.09 | 420,966 | +4.99% | +$223,200.02 | 2.98 | |
| Corcept Therapeutics Incorporated CORT | $2.14M | 0.08 | 85,000 | New | +$2.14M | 1.36 | |
| Axsome Therapeutics, Inc. AXSM | $2.59M | 0.07 | 32,500 | New | +$2.59M | 1.65 | |
| Amicus Therapeutics, Inc. FOLD | $2.06M | 0.06 | 175,000 | +25% | +$412,300.00 | 1.31 | |
| Celldex Therapeutics, Inc. CLDX | $1.62M | 0.06 | 38,500 | New | +$1.62M | 1.03 | |
| PROCEPT BioRobotics Corporation PRCT | $1.24M | 0.05 | 25,000 | New | +$1.24M | 0.78 | |
| MGIC Investment Corporation MTG | $2.56M | 0.04 | 114,379 | +44.09% | +$782,599.86 | 1.62 | |
| United Therapeutics Corporation UTHR | $3.68M | 0.04 | 16,000 | New | +$3.68M | 2.33 | |
| Enact Holdings, Inc. ACT | $1.32M | 0.03 | 42,367 | 0% | +$0 | 0.84 | |
Cerevel Therapeutics Holdings, Inc. CERE | $1.8M | 0.02 | 42,500 | +70% | +$739,725.00 | 1.14 | |
| Intra-Cellular Therapies, Inc. ITCI | $1.38M | 0.02 | 20,000 | 0% | +$0 | 0.88 | |
| Exact Sciences Corporation EXAS | $2M | 0.02 | 29,000 | New | +$2M | 1.27 | |
| Viking Therapeutics, Inc. VKTX | $1.48M | 0.02 | 18,000 | New | +$1.48M | 0.94 | |
argenx SE ARGX | $3.15M | 0.01 | 8,000 | +3.23% | +$98,430.00 | 2 | |
| Equity LifeStyle Properties, Inc. ELS | $1.33M | 0.01 | 20,611 | 0% | +$0 | 0.84 | |
Royalty Pharma plc RPRX | $1.82M | 0.01 | 60,000 | +50% | +$607,400.00 | 1.16 | |
| BioMarin Pharmaceutical Inc. BMRN | $1.35M | 0.01 | 15,500 | +10.71% | +$131,010.00 | 0.86 | |
| Pfizer Inc. PFE | $4.86M | <0.01 | 175,000 | +118.75% | +$2.64M | 3.08 | |
GSK plc GSK | $1.5M | <0.01 | 35,000 | 0% | +$0 | 0.95 | |
| Synopsys, Inc. SNPS | $1.43M | <0.01 | 2,500 | +19.05% | +$228,600.00 | 0.91 | |
| Medtronic plc MDT | $1.79M | <0.01 | 20,500 | 0% | +$0 | 1.13 | |
| BeiGene, Ltd. BGNE | $2.62M | <0.01 | 16,750 | +123.33% | +$1.45M | 1.66 | |
iShares Russell 1000 Value ETF IWD | $1.55M | <0.01 | 8,671 | New | +$1.55M | 0.99 | |
Invesco S&P 500 Pure Value ETF RPV | $1.58M | <0.01 | 17,834 | New | +$1.58M | 1 |